ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
November 30, 2023 at 20:35 PM EST
Shares of ImmunoGen Inc. close to doubled this morning after AbbVie Inc. said it will buy the cancer therapies company for $10.1 billion.
Photography by Christophe Tomatis